BEIJING, Feb. 25, 2019 /PRNewswire/ -- China Biologic
Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the
"Company"), a leading fully integrated plasma-based
biopharmaceutical company in China, today announced that the Company plans
to release its fourth quarter and fiscal year 2018 financial
results on Wednesday, March 6, 2019
after the market closes.
The Company's management will hold a conference call at
7:30 a.m. ET on Thursday, March
7, 2019, which is 8:30 p.m. Beijing
Time on March 7, 2019, to discuss
fourth quarter and fiscal year 2018 results. Listeners may access
the call by dialing:
US:
|
1 888 346
8982
|
International:
|
1 412 902
4272
|
Hong
Kong:
|
800 905945
|
China:
|
4001
201203
|
A telephone replay will be available one hour after the
conclusion of the conference call through March 14, 2019. The dial-in details are:
US:
|
1 877 344
7529
|
International:
|
1 412 317
0088
|
Passcode:
|
10129171
|
A live and archived webcast of the conference call will be
available through the Company's investor relations website at
http://chinabiologic.investorroom.com/.
About China Biologic Products Holdings, Inc.
China Biologic Products Holdings, Inc. (NASDAQ: CBPO) is a
leading fully integrated plasma-based biopharmaceutical company in
China. The Company's products are
used as critical therapies during medical emergencies and for the
prevention and treatment of life-threatening diseases and
immune-deficiency related diseases. China Biologic is headquartered
in Beijing and manufactures over
20 different dosage forms of plasma products through its indirect
majority-owned subsidiary, Shandong Taibang Biological Products
Co., Ltd. and its wholly owned subsidiary, Guizhou Taibang
Biological Products Co., Ltd. The Company also has an equity
investment in Xi'an Huitian Blood Products Co., Ltd. The Company
sells its products to hospitals, distributors and other healthcare
facilities in China. For
additional information, please see the Company's website
www.chinabiologic.com.
Contact:
China Biologic Products Holdings, Inc.
Mr. Ming Yin
Senior Vice President
Phone: +86-10-6598-3099
Email: ir@chinabiologic.com
The Foote Group
Mr. Philip Lisio
Phone: +86-135-0116-6560
E-mail: phil@thefootegroup.com
View original
content:http://www.prnewswire.com/news-releases/china-biologic-products-to-report-fourth-quarter-and-fiscal-year-2018-financial-results-300801029.html
SOURCE China Biologic Products Holdings, Inc.